Search

Author/Creator Oiartzabal, I.

1. Clinical and Biological Significance of Y Chromosome Loss in a Series of 2, 423 Male Patients with MDS and CMML. (April 2017)

Authors:
Costa, D.; Nomdedeu, M.; Pereira, A.; Calvo, X.; Colomer, J.; Soler, F.; Luno, E.; Cervera, J.; Arnan, M.; Ramos, F.; Oiartzabal, I.; Arrizabalaga, B.; Tormo, M.; Diez-campelo, M.; Ortega, M.; Collado, R.; Granada, I.; Sanz, G.; Campo, E.; Esteve, J.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale. Issue 5 (September 2015)

Authors:
Bonanad, S.; De la Rubia, J.; Gironella, M.; Pérez Persona, E.; González, B.; Fernández Lago, C.; Arnan, M.; Zudaire, M.; Hernández Rivas, J.A.; Soler, A.; Marrero, C.; Olivier, C.; Altés, A.; Valcárcel, D.; Hernández, M.T.; Oiartzabal, I.; Fernández Ordoño, R.; Arnao, M.; Esquerra, A.; Sarrá, J.
Journal:
Journal of geriatric oncology
Issue:
Volume 6:Issue 5(2015)
Page Start:
353
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. (23rd June 2022)

Authors:
Tamariz-Amador, L.-E.; Battaglia, A. M.; Maia, C.; Zherniakova, A.; Guerrero, C.; Zabaleta, A.; Burgos, L.; Botta, C.; Fortuño, M.-A.; Alignani, D.; Blanco, L.; Grande, C.; Manubens, A.; Arguiñano, J.-M.; Gomez, C.; Perez-Persona, E.; Olazabal, I.; Oiartzabal, I.; Panizo, C.; Prosper, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1474
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Topic: AS02-Epidemiology: COMPARISON OF CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED MDS (T-MDS) AND 4738 PATIENTS FROM THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM DATABASE WITH PRIMARY-MDS (P-MDS). (September 2021)

Authors:
Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Malcovati, L.; Dezern, A.; Roboz, G.; Steensma, D.; Haase, D.; Stauder, R.; Cedena, M.T.; Van De Loosdrecht, A.; Schlenk, R.; Blum, S.; Grau, J.; Calvo, X.
Journal:
Leukemia research
Issue:
Volume 108(2021)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS). (May 2023)

Authors:
Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Dezern, A.; Roboz, G.; Steensma, D.; Van De Loosdrecht, A.; Malcovati, L.; Schlenk, R.; Grau, J.; Calvo, X.; Blum, S.; Pereira, A.; Valent, P.; Costa, D.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗